# Shenzhen Kangmei biological Polytron Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-kangmei-biological-polytron-technologies

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.uni-smart.com
- Total disclosed funding: $15M
- Latest round: Series C (Sep 26, 2013)
- Investors on record: 3

## About

Established in 2007 and based in Shenzhen, China, Shenzhen Kangmei biological Polytron Technologies Inc. is a medical company that conducts research and development, production and sales of biomedical products. The company is headquartered in Shenzhen and has branches in Beijing and Wuhan.

The company’s main business is the research and development of in vitro diagnostic reagents. The company’s self-developed products include nucleic acid detection kits for Neisseria gonorrhoeae, Chlamydia trachomatis, and Urea plasma urealyticum. Its products are used in the field of clinical diagnostics.

The company generates revenue by providing diagnostic reagents and instruments.

## Funding rounds

- Series C, Sep 26, 2013, $4.2M — Wuyue Capital, Changzhou Gaoxintou Venture
- Series B, Sep 25, 2012, $3.3M — Wuyue Capital
- Series A, Sep 28, 2011, $7.7M — Wuyue Capital
- Angel, Dec 29, 2007, $0.1M — Shenzhen HTI

## Investors

- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Angel
- Wuyue Capital (https://capitalatlas.ai/funds/wuyue-capital) — Series A, Series B, Series C
- Changzhou Gaoxintou Venture (https://capitalatlas.ai/funds/changzhou-gaoxintou-venture) — Series C